btlines

MDG GPW sWIG80 Periodic report · PAP Biznes

Medicalgorithmics SA (MDG) · Q1 2026 results

Share price: 20.45 zł · 2026-11-10

Results Q1 2026 vs Q1 2025 · year over year · published 28 May 2026 and 30 May 2025

Net loss narrowed year on year. The language turned more upbeat.

Only a basic analysis is available for this company at the moment.

1 · Numbers

Loss narrowed

Net income vs Q1 2025

Net income -2.1M vs -3.9M

Revenue +60.3%

2 · How the report reads

More upbeat

Language tone vs last period

Report language: upbeat for a company report — more upbeat than in Q1 2025.

Weak signal: formal report language, not a call.

3 · What stood out

New

The parties committed to converting a loan into a commission from new client revenues and reducing the interest rate from 18.5% to 14% per annum.

Valuation

Reverse DCF. Free cash flow from the last full fiscal year, grown for 10 years, discounted back, plus a terminal value. “Implied growth” is the rate the current price assumes.

Valuation unavailable: free cash flow and profit were negative in the last full year and on average over the last three, so there is nothing to discount.

Current price

20.45 zł

close of 2026-11-10

Revenue growth, 3 years

−20.9% a year

compound annual rate (CAGR)

Official channels

The company's own website and social media accounts.

Read between the lines

No major shifts flagged this period.

Tone

How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q1 2026. Ring: Q1 2025.

Report language Upbeat (was typical)

Upbeat for a company report — more upbeat than in Q1 2025. Periodic reports carry legally required risk wording, so their tone moves little and is a weak signal.

Sentences that drove the tone
“The company's exposure to interest rate changes, as well as other financial risks (including currency exchange rate risk and liquidity risk), are presented in note 27 of the Consolidated Financial Statements for 2025...”
“The Group cannot, however, rule out that in the long term, the undoubtedly negative impact of the war on the general economic situation in Poland and globally may also have an unfavorable impact on the operation of or...”
“At the same time, the Group consistently implements the development strategy published in June 2023 and is at the stage of expanding its customer base leading to revenue growth.”

Full figures

PLN · PAP Biznes report (2026-05-28)

Metric Q1 2026 Q1 2025 Change
Revenue 10.2M 6.4M +60.3%
Gross profit -1.1M —
Operating income -373.0K —
Net income -2.1M -3.9M Loss narrowed
P/E 12-mo loss 12-mo loss —

Topics

Topics are drawn from the full report text, not management commentary.

Most discussed now

  • New Loans for the Company's shares up to the amount of the Company's obligation indicated in the Annex in the total amount of 16,520,460.47…
  • New IFRS 18 aims to improve financial reporting by introducing a requirement for additional defined subtotals in the statement of profit or loss
  • New DeepRhythmAI (DRAI) is a set of artificial intelligence algorithms, utilizing the most advanced AI algorithm models, designed to provide…
  • New In the next three years, DRP will fully replace PC Client software as the primary arrhythmia diagnostics software used by clients.
  • New In response to the identified risks, the Management Board has taken and continues to take actions aimed at ensuring the Company's business…

Top topics in Q1 2025

  • Nothing dropped away.

Latest announcements

Official filings, newest first.

Similar companies

Healthcare · Medical Devices
All Healthcare companies →